Advanced Biomed Inc. income statement

In fiscal 2026, Advanced Biomed Inc. reported revenue of $127,637, operating income of −$6.2m (a -4883.8% margin) and net income of $6.7m, or $5.33 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Advanced Biomed Inc.: income statement, annual
Fiscal year	2026Jun 2026
Revenue	128
General and administrative	4,627
Operating income	−6,234
Income before tax	−6,262
Income tax	−1
Net income	6,677
Diluted EPS	$5.33
Diluted shares (average)	1m

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Advanced Biomed Inc.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Advanced Biomed Inc.